Transparency data

UK NSC meeting agenda November 2025

Updated 8 January 2026

© Crown copyright 2026

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/uk-nsc-meeting-november-2025/uk-nsc-meeting-agenda-november-2025

The 27 November 2025 agenda for the UK National Screening Committee (UK NSC) meeting being held in London and over Microsoft Teams is as follows:

  • introduction and apologies
  • call for new interests
  • minutes of the last meeting
  • matters arising – director’s update
  • draft prostate cancer screening recommendation for public consultation
  • newborn screening for metachromatic leukodystrophy (MLD)
  • adult screening for dementia
  • digital cytology in cervical screening and triage – next steps post evidence map
  • heart valve disease
  • Equipoise (multi-condition newborn blood spot screening in-service evaluation project)
  • additional breast screening for women with dense breasts
  • stakeholder activity update, including UK NSC stakeholder review report and action plan

  • Fetal Maternal Child Health (FMCH) Group update

  • Adult Reference Group (ARG) update
    • Breast Task Group
    • screening for cardiac conditions associated with sudden cardiac death (SCD) in the young
    • osteoporosis
  • Research and Methodology Group (RMG) update
  • any other business
    • consultation has now closed on newborn screening for extended severe combined immunodeficiencies (SCID) and will go to FMCH to review comments
Back to top